Intrexon | XON - Ativos

Preço das Ações
4.16
Mudança Diária
-0.11 -2.58%
Mensal
21.64%
Anual
197.14%
Q2 Previsão
4.05




Ativos Alterar Data
Agenus USD 226.8M 7.09M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Amgen USD 90.59B 445M 2025-12
Anika Therapeutics USD 190.27M 833K 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
MacroGenics USD 256.85M 13.92M 2025-12
MannKind USD 792.18M 297.54M 2025-12
Merck USD 129.55B 12.02B 2025-09
Novartis USD 110.95B 3.66B 2025-12
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Veracyte USD 1.41B 38.23M 2025-12
Xencor USD 875.5M 6.68M 2025-12